Skip to content
Home/Companies/Healthcare/Rarecells
Rarecells

Rarecells

Healthcare·France·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Rarecells?

Rarecells is currently owned by Yaday through AA Sons Legacy (2016 vintage), since 2020.

Hand-verified · updated 2026-04-21

Yaday
Investor
Yaday
AA Sons Legacy · 2016 · VC

Key facts

HQFrance
SectorHealthcare
Websitewww.rarecells.com

More from AA Sons Legacy

Other portfolio companies in the same fund.

Stage11
Stage11
Active
TMTFrance· 2022
Aeler
Aeler
Active
IndustrialsSwitzerland· 2021
AnnaBella
AnnaBella
Active
ConsumerFrance· 2021
BodyVision Medical
BodyVision Medical
Active
HealthcareIsrael· 2021
Bruvi
Bruvi
Active
ConsumerUS· 2021
Cashbee
Cashbee
Active
FinancialsFrance· 2021

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Rarecells

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Rarecells?

4 strategic and 116financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Rarecells.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue